U.S. ARKRAY, Inc. announces the launch of the AUTION ELEVEN™ AE-4022 Semi-Automated Urine Analyzer

Wednesday, February 22, 2017 Research News J E 4

EDINA, Minn., Feb. 22, 2017 /PRNewswire/ -- U.S. ARKRAY, Inc. (ARKRAY) announces the launch of the AUTION ELEVEN™ AE-4022 Semi-Automated Urine Analyzer – The newest member of the AUTION family of urinalysis instruments.

"The AUTION ELEVEN builds on the proven technology of the fully automated AUTION HYBRID™ AU-4050, AUTION MAX™ AX-4280, AUTION MAX™ AX-4030 and the AUTION test strip technology which has delivered dependable quality patient results since 1972," said Shane Hawes, General Manager ARKRAY.

Now you can standardize urinalysis results across a hospital network with the ARKRAY AUTION urinalysis product portfolio using AUTION ELEVEN AE-4022. The Semi-Automated Urine Chemistry Analyzer is ideal as a standalone analyzer in medium to high volume laboratories, as well as a back-up solution for fully automated urine analyzers.

The AUTION ELEVEN AE-4022 generates quality results using the AUTION Sticks 10EA. The stick technology is identical to the AUTION Sticks 9EB and Uriflet S 9HA.  When placed on the analyzer they are automatically read eliminating tech to tech variability and potential errors.

The analyzer is simple to operate. In auto start mode, AUTION Sticks 10EA can be continuously placed every 7 seconds minimizing workflow interruptions. Once sticks are placed they are automatically aligned to ensure proper placement.

The space saving design makes the AUTION ELEVEN AE-4022 the smallest semi-automated urine chemistry analyzer on the market. It maximizes laboratory space and can be easily transported.

AUTION ELEVEN AE-4022 ensures quality and compliance with enhanced software. The software can be configured to automatically prompt users to perform QC testing, prevent testing if QC is not performed, and restrict instrument use with Operator ID lockout.

U.S. ARKRAY, Inc. is a wholly owned subsidiary of ARKRAY, Inc. of Kyoto, Japan. ARKRAY, Inc. was founded in 1960 as Kyoto Daiichi Kagaku Inc. (KDK). ARKRAY is a global leader in urinalysis and continues to develop innovative diagnostic products including automated urinalysis and HbA1c systems. For more information, please visit


To view the original version on PR Newswire, visit:




You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
CMPA supports expansion of CanMEDS to educate and ...
EDOF Support Leads to Ground-breaking Face Transpl...